InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.080 0.001 (1.23%)+

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Board Changes Effected 2 Dec 2024 9:18AM $0.092 $0.080 fallen by 13.04%
$28 Application for quotation of securities - RHY 27 Nov 2024 3:51PM $0.094 $0.080 fallen by 14.89%
$28 Final Director's Interest Notice - Lou Panaccio 21 Nov 2024 3:21PM $0.140 $0.080 fallen by 42.86%
$28 Final Director's Interest Notice - Trevor Lockett 21 Nov 2024 3:17PM $0.140 $0.080 fallen by 42.86%
$28 2024 AGM Results 20 Nov 2024 4:43PM $0.130 $0.080 fallen by 38.46%
$28 2024 AGM Chairman's Address & Post AGM Presentation 20 Nov 2024 12:02PM $0.120 $0.080 fallen by 33.33%
$28 Board Composition Update - NED Resignations 20 Nov 2024 11:19AM $0.120 $0.080 fallen by 33.33%
$28 Proposed issue of securities - RHY 19 Nov 2024 10:36AM $0.115 $0.080 fallen by 30.43%
$28 Placement Issue Investor Presentation 19 Nov 2024 10:36AM $0.115 $0.080 fallen by 30.43%
$28 Placement Prospectus 19 Nov 2024 10:36AM $0.115 $0.080 fallen by 30.43%
$28 Strong Demand in Share Placement to Raise $3.5 million 19 Nov 2024 10:19AM $0.115 $0.080 fallen by 30.43%
$28 Notification regarding unquoted securities - RHY 18 Nov 2024 9:42AM $0.115 $0.080 fallen by 30.43%
$28 Notification regarding unquoted securities - RHY 18 Nov 2024 9:42AM $0.115 $0.080 fallen by 30.43%
$28 Awarding of Employee Options and Loan Shares to Management 18 Nov 2024 9:32AM $0.115 $0.080 fallen by 30.43%
$28 Trading Halt 15 Nov 2024 9:21AM $0.115 $0.080 fallen by 30.43%
$28 New, Independent, Non-Executive Director to be Appointed 11 Nov 2024 9:17AM $0.110 $0.080 fallen by 27.27%
$28 Receipt of Research & Development Tax Incentive 7 Nov 2024 9:03AM $0.105 $0.080 fallen by 23.81%
$28 Market Presentation 24 Oct 2024 9:21AM $0.110 $0.080 fallen by 27.27%
$28 Appendix 4C and Market Update 24 Oct 2024 8:56AM $0.110 $0.080 fallen by 27.27%
$28 RHY 2024 AGM Nominations & Proxy Form 18 Oct 2024 9:03AM $0.100 $0.080 fallen by 20%
$28 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms 7 Oct 2024 9:51AM $0.076 $0.080 risen by 5.26%
$28 Initial Director's Interest Notice - David Atkins 30 Sep 2024 8:55AM $0.070 $0.080 risen by 14.29%
$28 Board Renewal / Composition Update 30 Sep 2024 8:51AM $0.070 $0.080 risen by 14.29%
$28 Corporate Governance Statement 26 Sep 2024 9:21AM $0.073 $0.080 risen by 9.59%
$28 RHY FY2024 Annual Report 26 Sep 2024 9:19AM $0.073 $0.080 risen by 9.59%

176 - 200 of 651 results

Page 8 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.